Loading...
Penumbra, Inc.
PEN•NYSE
Healthcare
Medical - Devices
$233.10
$2.92(1.27%)
Penumbra, Inc. (PEN) Financial Performance & Income Statement Overview
Review Penumbra, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.86%
↑ 12.86%
Operating Income Growth
-87.38%
↓ 87.38%
Net Income Growth
-84.59%
↓ 84.59%
Operating Cash Flow Growth
73.10%
↑ 73.10%
Operating Margin
9.23%
↑ 9.23%
Gross Margin
63.48%
↑ 63.48%
Net Profit Margin
3.41%
↑ 3.41%
ROE
3.65%
↑ 3.65%
ROIC
7.98%
↑ 7.98%
Penumbra, Inc. (PEN) Income Statement & Financial Overview
Review Penumbra, Inc.'s (PEN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $315.52M | $301.04M | $299.40M | $278.65M |
| Cost of Revenue | $104.80M | $100.73M | $139.06M | $100.003M |
| Gross Profit | $210.72M | $200.31M | $160.34M | $178.65M |
| Gross Profit Ratio | $0.67 | $0.67 | $0.54 | $0.64 |
| R&D Expenses | $20.01M | $25.20M | $24.94M | $24.63M |
| SG&A Expenses | $147.94M | $139.74M | $139.42M | $141.93M |
| Operating Expenses | $167.95M | $164.94M | $164.36M | $166.55M |
| Total Costs & Expenses | $272.74M | $265.68M | $303.42M | $266.55M |
| Interest Income | $3.28M | $3.46M | $3.66M | $0.00 |
| Interest Expense | $337000.00 | $336000.00 | $344000.00 | $0.00 |
| Depreciation & Amortization | $4.39M | $4.15M | $7.65M | $7.52M |
| EBITDA | $49.06M | $44.26M | -$69.88M | $19.62M |
| EBITDA Ratio | $0.16 | $0.15 | -$0.23 | $0.07 |
| Operating Income | $42.77M | $35.36M | -$4.02M | $12.10M |
| Operating Income Ratio | $0.14 | $0.12 | -$0.01 | $0.04 |
| Other Income/Expenses (Net) | $1.56M | $4.41M | $3.09M | $2.52M |
| Income Before Tax | $44.34M | $39.78M | -$77.87M | $14.63M |
| Income Before Tax Ratio | $0.14 | $0.13 | -$0.26 | $0.05 |
| Income Tax Expense | $10.66M | $10.25M | -$17.67M | $3.62M |
| Net Income | $33.68M | $29.53M | -$60.20M | $11.002M |
| Net Income Ratio | $0.11 | $0.10 | -$0.20 | $0.04 |
| EPS | $0.87 | $0.76 | -$1.55 | $0.28 |
| Diluted EPS | $0.86 | $0.75 | -$1.55 | $0.28 |
| Weighted Avg Shares Outstanding | $38.63M | $38.61M | $38.79M | $38.72M |
| Weighted Avg Shares Outstanding (Diluted) | $39.27M | $39.18M | $38.79M | $39.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan